Yahoo Finance Live anchors discuss stock performance for cruise lines.
Leaving these accounts open could tarnish your golden years.
Yahoo Finance Live examines Carnival Cruise's stock after its latest earnings miss signifies a much longer path to profitability than expected.
September is living up to its reputation as an ugly month for stocks. Here's what the data says about October performance.
Yahoo Finance Live's Seana Smith looks at several stocks trending in the after-hours trading session.
Meta Platforms is not doing well. The social-media giant, parent of Facebook, Instagram and WhatsApp, has been sending alarming signals for several months. It was ejected from the world's top 10 most valuable companies, and this year its market capitalization has fallen by nearly $545 billion.
In spite of market turmoil, this year has been bright so far for AbbVie (NYSE: ABBV). The company's star drug Humira continues to grow, and even reached the milestone of more than $20 billion in sales last year. Its other immunology drugs and the neuroscience business also are thriving.
Yahoo Finance Live looks at the latest news surrounding the debut of Tesla's humanoid A.I. robot.
The bear market in software stocks has already lasted far longer than the typical decline, according to MoffettNathanson,
These two energy stocks largely avoid the ups and downs of oil prices, while this other one is tied directly to those gyrations.
Inflation, interest rates, and recession – these are the bogeymen of investing, and they’ve been watching over our shoulders for the past several months. We all know the story by now, the rate of inflation is running at generational highs, the Federal Reserve is hiking rates in an attempt to push back against high prices, and that’s likely to tip the economy into recession. At a time like this, investors are showing a growing interest in finding strong defensive portfolio moves. It’s a mindset t
Semiconductor stocks have tumbled in recent months amid flagging demand, with the S&P Semiconductors Select Industry Index dropping 36% year to date. Bank of America analysts recently discussed their favorite choices in the sector.
Portfolio Wealth Advisors President and CIO Lee Munson and Sound Planning Group CEO David Stryzewski join Yahoo Finance Live to discuss the recent market volatility, inflation, rising rates, and more.
Shares of gene therapy company Bluebird Bio (NASDAQ: BLUE) were up by a healthy 12.4% on heavy volume as of 11:16 a.m. ET Friday morning. The biotech's stock appears to be getting a boost from both a broad upward trend across the biotechnology space today, as well as from rumors circulating on social media about a possible buyout. Bluebird scored two approvals from the Food and Drug Administration (FDA) earlier this year for its one-and-done gene therapies: Skysona for cerebral adrenoleukodystrophy (CALD) and Zynteglo for transfusion-dependent beta-thalassemia (TDT).
Elon Musk has said the robot could more important than its car business, but it'll join a long list of projects that haven't yet seen the light of day.
The fuel cell stocks are both gaining traction in hydrogen markets. Bloom Energy has the edge when it comes to materials.
The Dow Jones Industrial Average dropped Friday on hot inflation data. Tesla stock fell ahead of the company's AI Day.
Carly is staying on top of the story and reports that there is “no immediate fix.” Eyeing that sweet capital: Manish has a scoop that Uniswap Labs, a decentralized exchange, is going after over $100 million in new funding. Stream on: YouTube TV is offering a new à la carte option that enables subscribers to purchase stand-alone networks without subscribing to the full channel lineup in its Base plan, Lauren reports.